NMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130024, China.
NMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130024, China; National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130117, China.
J Adv Res. 2024 Nov;65:89-104. doi: 10.1016/j.jare.2024.04.033. Epub 2024 May 7.
Ovarian cancer (OC) is known for its high mortality rate. Although sodium citrate has anti-tumor effects in various cancers, its effect and mechanism in OC remain unclear.
To analyze the inhibitory effect of sodium citrate on ovarian cancer cells and the underlying mechanism.
Cell apoptosis was examined by TUNEL staining, flow cytometry, and ferroptosis was examined intracellular Fe, MDA, LPO assays, respectively. Cell metabolism was examined by OCR and ECAR measurements. Immunoblotting and immunoprecipitation were used to elucidate the mechanism.
This study suggested that sodium citrate not only promoted ovarian cancer cell apoptosis but also triggeredferroptosis, manifested as elevated levels of Fe, LPO, MDA andlipid ROS production. On one hand, sodium citrate treatment led to a decrease of Ca content in the cytosol by chelatingCa, which further inhibited the Ca/CAMKK2/AKT/mTOR signaling, thereby suppressing HIF1α-dependent glycolysis pathway and inducing cell apoptosis. On the other hand, the chelation of Ca by sodium citrate resulted in inactivation of CAMKK2 and AMPK, leading to increase of NCOA4-mediated ferritinophagy, causing increased intracellular Fe levels. More importantly, the inhibition of Ca/CAMKK2/AMPK signaling pathway reduced the activity of the MCU and Ca concentration within the mitochondria, resulting in an increase in mitochondrial ROS. Additionally, metabolomic analysis indicated that sodium citrate treatment significantly increased de novo lipid synthesis. Altogether, these factors contributed to ferroptosis. As expected, Ca supplementation successfully reversed the cell death and decreased tumor growth induced by sodium citrate. Inspiringly, it was found that coadministration of sodium citrate increased the sensitivity of OC cells to chemo-drugs.
These results revealed that the sodium citrate exerted its anti-cancer activity by inhibiting Ca/CAMKK2-dependent cell apoptosis and ferroptosis. Sodium citrate will hopefully serve as a prospective compound for OC treatment and for improvingthe efficacy of chemo-drugs.
卵巢癌(OC)死亡率高。柠檬酸纳在多种癌症中具有抗肿瘤作用,但在 OC 中的作用和机制尚不清楚。
分析柠檬酸纳对卵巢癌细胞的抑制作用及其机制。
通过 TUNEL 染色、流式细胞术分析细胞凋亡,通过细胞内铁、MDA、LPO 测定分别检测铁死亡,通过 OCR 和 ECAR 测定分析细胞代谢。采用免疫印迹和免疫沉淀法阐明机制。
本研究表明,柠檬酸纳不仅促进卵巢癌细胞凋亡,还触发铁死亡,表现为 Fe、LPO、MDA 和脂质 ROS 产生增加。一方面,柠檬酸纳通过螯合 Ca 导致细胞质 Ca 含量减少,从而抑制 Ca/CAMKK2/AKT/mTOR 信号通路,抑制 HIF1α 依赖性糖酵解途径,诱导细胞凋亡。另一方面,柠檬酸纳螯合 Ca 导致 CAMKK2 和 AMPK 失活,增加 NCOA4 介导的铁蛋白自噬,导致细胞内 Fe 水平升高。更重要的是,Ca/CAMKK2/AMPK 信号通路的抑制降低了 MCU 的活性和线粒体内部的 Ca 浓度,导致线粒体 ROS 增加。此外,代谢组学分析表明,柠檬酸纳处理显著增加了从头脂质合成。总之,这些因素促成了铁死亡。正如预期的那样,Ca 补充成功逆转了柠檬酸纳诱导的细胞死亡和肿瘤生长减少。令人鼓舞的是,发现联合使用柠檬酸纳增加了 OC 细胞对化疗药物的敏感性。
这些结果表明,柠檬酸纳通过抑制 Ca/CAMKK2 依赖性细胞凋亡和铁死亡发挥其抗癌活性。柠檬酸纳有望成为 OC 治疗和提高化疗药物疗效的有前途的化合物。